CARDIOPULMONARY BYPASS
Clinical trials for CARDIOPULMONARY BYPASS explained in plain language.
Never miss a new study
Get alerted when new CARDIOPULMONARY BYPASS trials appear
Sign up with your email to follow new studies for CARDIOPULMONARY BYPASS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria boost may shield organs after heart surgery
Disease control ENROLLING_BY_INVITATIONThis study tests whether a probiotic supplement called Probacine can protect the gut and reduce organ damage in 500 adults after heart surgery. Researchers believe that changing the gut microbiome may improve recovery. Participants will take Probacine before and after surgery, an…
Matched conditions: CARDIOPULMONARY BYPASS
Phase: NA • Sponsor: Nanjing Medical University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New oxygen strategy could save young hearts after surgery
Disease control ENROLLING_BY_INVITATIONThis study tests a new way to manage blood flow and oxygen in children after heart surgery. The goal is to prevent serious problems like low blood pressure and cardiac arrest by focusing on oxygen use in the body during the critical first 8 hours after surgery. About 300 children…
Matched conditions: CARDIOPULMONARY BYPASS
Phase: NA • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug aims to shield kidneys during heart surgery for CKD patients
Disease control OngoingThis study tests if a single dose of ravulizumab can prevent serious kidney problems after heart surgery in adults with chronic kidney disease (CKD). About 736 participants will receive either the drug or a placebo before surgery. The goal is to see if the drug reduces the risk o…
Matched conditions: CARDIOPULMONARY BYPASS
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
AI could help heart surgery patients get the right Anti-Inflammatory drug
Knowledge-focused OngoingThis study looks at data from 10,000 heart surgery patients to build an AI tool that helps doctors decide who will benefit from a drug called ulinastatin. The drug may reduce inflammation and complications after surgery, but it doesn't work for everyone. The goal is to match the …
Matched conditions: CARDIOPULMONARY BYPASS
Sponsor: Beijing Anzhen Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 15:08 UTC